Big Pharma Teams Up with St. Louis Vaccine Startup & Why it Matters
Omniose, a St. Louis biotech startup focused on developing vaccines for bacterial infections, has entered into a 3-year research agreement with AstraZeneca, the gigantic pharmaceutical firm known for developing Britain’s COVID-19 vaccine. EQ speaks to the STL startup founder and explains 2 reasons why this is good news for St. Louis.
The post Big Pharma Teams Up with St. Louis Vaccine Startup & Why it Matters appeared first on EQ.
stLouIST